These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


318 related items for PubMed ID: 16084822

  • 21. Use of surface EMG for evaluation of upper limb spasticity during botulinum toxin therapy in stroke patients.
    Albani G, Cimolin V, Galli M, Vimercati S, Bar D, Campanelli L, Gandolfi R, Lombardi R, Mauro A.
    Funct Neurol; 2010; 25(2):103-7. PubMed ID: 20923608
    [Abstract] [Full Text] [Related]

  • 22. Safety and efficacy of incobotulinum toxin type A (NT 201-Xeomin) for the treatment of post-stroke lower limb spasticity: a prospective open-label study.
    Santamato A, Micello MF, Panza F, Fortunato F, Pilotto A, Giustini A, Testa A, Fiore P, Ranieri M, Spidalieri R.
    Eur J Phys Rehabil Med; 2013 Aug; 49(4):483-9. PubMed ID: 23480980
    [Abstract] [Full Text] [Related]

  • 23. Spasticity measurement based on tonic stretch reflex threshold in stroke using a portable device.
    Calota A, Feldman AG, Levin MF.
    Clin Neurophysiol; 2008 Oct; 119(10):2329-37. PubMed ID: 18762451
    [Abstract] [Full Text] [Related]

  • 24. Cortical somatosensory evoked potentials and spasticity assessment after botulinum toxin type A injection in children with cerebral palsy.
    Boćkowski L, Okurowska-Zawada B, Sobaniec W, Kułak W, Sendrowski K.
    Adv Med Sci; 2007 Oct; 52 Suppl 1():171-5. PubMed ID: 18229658
    [Abstract] [Full Text] [Related]

  • 25. The effect of electro-acupuncture on spasticity of the wrist joint in chronic stroke survivors.
    Mukherjee M, McPeak LK, Redford JB, Sun C, Liu W.
    Arch Phys Med Rehabil; 2007 Feb; 88(2):159-66. PubMed ID: 17270512
    [Abstract] [Full Text] [Related]

  • 26. Serial injection of botulinum toxin for muscle imbalance due to regional spasticity in the upper limb.
    Turner-Stokes L, Ashford S.
    Disabil Rehabil; 2007 Dec 15; 29(23):1806-12. PubMed ID: 18033605
    [Abstract] [Full Text] [Related]

  • 27. Management of shoulder and proximal upper limb spasticity using botulinum toxin and concurrent therapy interventions: a preliminary analysis of goals and outcomes.
    Ashford S, Turner-Stokes L.
    Disabil Rehabil; 2009 Dec 15; 31(3):220-6. PubMed ID: 18608366
    [Abstract] [Full Text] [Related]

  • 28. Evaluation of spastic muscle in stroke survivors using magnetic resonance imaging and resistance to passive motion.
    Ploutz-Snyder LL, Clark BC, Logan L, Turk M.
    Arch Phys Med Rehabil; 2006 Dec 15; 87(12):1636-42. PubMed ID: 17141645
    [Abstract] [Full Text] [Related]

  • 29. Isokinetic assessment of the effects of botulinum toxin injection on spasticity and voluntary strength in patients with spastic hemiparesis.
    Hameau S, Bensmail D, Robertson J, Boudarham J, Roche N, Zory R.
    Eur J Phys Rehabil Med; 2014 Oct 15; 50(5):515-23. PubMed ID: 24651151
    [Abstract] [Full Text] [Related]

  • 30. Electromyographic response to manual passive stretch of the hemiplegic wrist: accuracy, reliability, and correlation with clinical spasticity assessment and function.
    Sorinola IO, White CM, Rushton DN, Newham DJ.
    Neurorehabil Neural Repair; 2009 Oct 15; 23(3):287-94. PubMed ID: 19050174
    [Abstract] [Full Text] [Related]

  • 31. Increased efficacy and decreased systemic-effects of botulinum toxin A injection after active or passive muscle manipulation.
    Minamoto VB, Hulst JB, Lim M, Peace WJ, Bremner SN, Ward SR, Lieber RL.
    Dev Med Child Neurol; 2007 Dec 15; 49(12):907-14. PubMed ID: 18039237
    [Abstract] [Full Text] [Related]

  • 32. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA, Speth LA, Duysens J, Vles JS, Smits-Engelsman BC.
    Neurorehabil Neural Repair; 2009 Dec 15; 23(3):218-25. PubMed ID: 19106252
    [Abstract] [Full Text] [Related]

  • 33. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC, Chuang YC, Liu JP, Chien KL, Chen YM, Chen YF.
    Clin Rehabil; 2009 Jan 15; 23(1):64-71. PubMed ID: 19114438
    [Abstract] [Full Text] [Related]

  • 34. Relation between spasticity, weakness and contracture of the elbow flexors and upper limb activity after stroke: an observational study.
    Ada L, O'Dwyer N, O'Neill E.
    Disabil Rehabil; 2009 Jan 15; 28(13-14):891-7. PubMed ID: 16777777
    [Abstract] [Full Text] [Related]

  • 35. Repeated botulinum toxin injections can improve mobility in patients with spinal cord lesions.
    Catz A, Barkol H, Steinberg F, Ronen J, Bluvshtein V, Keren O.
    Eura Medicophys; 2007 Sep 15; 43(3):319-25. PubMed ID: 17525702
    [Abstract] [Full Text] [Related]

  • 36. Effectiveness of botulinum toxin A in the treatment of spasticity of the lower extremities in adults - preliminary report.
    Opara J, Hordyńska E, Swoboda A.
    Ortop Traumatol Rehabil; 2007 Sep 15; 9(3):277-85. PubMed ID: 17721426
    [Abstract] [Full Text] [Related]

  • 37. Effects of botulinum toxin A on functional outcome during distraction osteogenesis.
    Olabisi R, Best TM, Vanderby R, Petr S, Noonan KJ.
    J Orthop Res; 2007 May 15; 25(5):656-64. PubMed ID: 17262822
    [Abstract] [Full Text] [Related]

  • 38. Intrafusal effects of botulinum toxin injections for spasticity: revisiting a previous paper.
    Phadke CP, On AY, Kirazli Y, Ismail F, Boulias C.
    Neurosci Lett; 2013 Apr 29; 541():20-3. PubMed ID: 23458671
    [Abstract] [Full Text] [Related]

  • 39. Dose-dependent response to intramuscular botulinum toxin type A for upper-limb spasticity in patients after a stroke.
    Childers MK, Brashear A, Jozefczyk P, Reding M, Alexander D, Good D, Walcott JM, Jenkins SW, Turkel C, Molloy PT.
    Arch Phys Med Rehabil; 2004 Jul 29; 85(7):1063-9. PubMed ID: 15241751
    [Abstract] [Full Text] [Related]

  • 40. Formation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: a pooled-data analysis of three clinical trials.
    Yablon SA, Brashear A, Gordon MF, Elovic EP, Turkel CC, Daggett S, Liu J, Brin MF.
    Clin Ther; 2007 Apr 29; 29(4):683-90. PubMed ID: 17617291
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 16.